HDGFL2 隐蔽蛋白：神经退行性疾病检测与诊断的关键切入点 - Suppr

Suppr

超能文献

HDGFL2 cryptic protein: a portal to detection and diagnosis in neurodegenerative disease.

作者信息

Albagli Ellen A, Calliari Anna, Gendron Tania F, Zhang Yong-Jie

机构信息

Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.

Neurobiology of Disease Graduate Program, Mayo Graduate School, Mayo Clinic College of Medicine, Rochester, MN, USA.

出版信息

Mol Neurodegener. 2024 Oct 25;19(1):79. doi: 10.1186/s13024-024-00768-y.

DOI:10.1186/s13024-024-00768-y

PMID:39456026

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11515212/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6362/11515212/d497674e5c1d/13024_2024_768_Fig1_HTML.jpg

相似文献

HDGFL2 cryptic protein: a portal to detection and diagnosis in neurodegenerative disease.HDGFL2 隐蔽蛋白：神经退行性疾病检测与诊断的关键切入点

Mol Neurodegener. 2024 Oct 25;19(1):79. doi: 10.1186/s13024-024-00768-y.

A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.一种体液生物标志物揭示了在症状前 ALS-FTD 中 TDP-43 剪接抑制的丧失。

Nat Med. 2024 Feb;30(2):382-393. doi: 10.1038/s41591-023-02788-5. Epub 2024 Jan 26.

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.额颞叶痴呆和肌萎缩侧索硬化的生物标志物发现与开发

Brain. 2022 Jun 3;145(5):1598-1609. doi: 10.1093/brain/awac077.

HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases.HDGFL2 隐秘蛋白报告神经退行性疾病中 TDP-43 病理学的存在。

Mol Neurodegener. 2024 Mar 27;19(1):29. doi: 10.1186/s13024-024-00718-8.

Cryptic inclusions UNCover losses driving neurodegeneration.隐秘内含物揭示导致神经退行性变的丧失。

Trends Genet. 2022 Sep;38(9):889-891. doi: 10.1016/j.tig.2022.06.004. Epub 2022 Jun 27.

Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.脑脊液TAR DNA结合蛋白43联合tau蛋白作为肌萎缩侧索硬化症和额颞叶痴呆谱系障碍的候选生物标志物

Dement Geriatr Cogn Disord. 2017;44(3-4):144-152. doi: 10.1159/000478979. Epub 2017 Aug 23.

A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS.一种流体生物标志物揭示了症状前肌萎缩侧索硬化症中TDP-43剪接抑制的丧失。

bioRxiv. 2023 Jan 24:2023.01.23.525202. doi: 10.1101/2023.01.23.525202.

Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.破解肌萎缩侧索硬化症和额颞叶痴呆症中的神秘密码：寻找治疗靶点和生物标志物。

Clin Transl Med. 2022 May;12(5):e818. doi: 10.1002/ctm2.818.

TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients.肌萎缩侧索硬化症和额颞叶痴呆患者脑脊液中TDP - 43实时震颤诱导转化反应的优化及种子活性检测

Brain Commun. 2020 Sep 14;2(2):fcaa142. doi: 10.1093/braincomms/fcaa142. eCollection 2020.

Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.蛋白质合成调节作为肌萎缩侧索硬化症和额颞叶痴呆的一种治疗方法。

Neural Regen Res. 2022 Jul;17(7):1423-1430. doi: 10.4103/1673-5374.330593.

引用本文的文献

Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions.神经退行性疾病中靶向小胶质细胞的生物标志物与治疗策略：现状与未来方向

Mol Neurodegener. 2025 Jul 10;20(1):82. doi: 10.1186/s13024-025-00867-4.

本文引用的文献

HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases.HDGFL2 隐秘蛋白报告神经退行性疾病中 TDP-43 病理学的存在。

Mol Neurodegener. 2024 Mar 27;19(1):29. doi: 10.1186/s13024-024-00718-8.

Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains.隐匿外显子包含是衰老大脑中 LATE-NC 的分子特征。

Acta Neuropathol. 2024 Feb 3;147(1):29. doi: 10.1007/s00401-023-02671-0.

A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.一种体液生物标志物揭示了在症状前 ALS-FTD 中 TDP-43 剪接抑制的丧失。

Nat Med. 2024 Feb;30(2):382-393. doi: 10.1038/s41591-023-02788-5. Epub 2024 Jan 26.

Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.错误剪接的转录本在与TDP-43相关的肌萎缩侧索硬化症/额颞叶痴呆中产生全新的蛋白质。

Sci Transl Med. 2024 Feb 14;16(734):eadg7162. doi: 10.1126/scitranslmed.adg7162.

Fluid biomarkers for amyotrophic lateral sclerosis: a review.肌萎缩侧索硬化症的液体生物标志物：综述。

Mol Neurodegener. 2024 Jan 24;19(1):9. doi: 10.1186/s13024-023-00685-6.

Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.STMN2 和 UNC13A mRNA 的剪接异常是 TDP-43 相关阿尔茨海默病的病理特征。

Acta Neuropathol. 2024 Jan 4;147(1):9. doi: 10.1007/s00401-023-02655-0.

NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing.NULISA：一种具有阿伏伽德罗灵敏度和高多重检测能力的蛋白质组学液体活检平台。

Nat Commun. 2023 Nov 9;14(1):7238. doi: 10.1038/s41467-023-42834-x.

TDP-43-regulated cryptic RNAs accumulate in Alzheimer's disease brains.TDP-43 调控的内源性 RNA 在阿尔茨海默病脑中积累。

Mol Neurodegener. 2023 Aug 21;18(1):57. doi: 10.1186/s13024-023-00646-z.

The era of cryptic exons: implications for ALS-FTD.隐匿外显子的时代：对 ALS-FTD 的影响。

Mol Neurodegener. 2023 Mar 15;18(1):16. doi: 10.1186/s13024-023-00608-5.

Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis.在散发型包涵体肌炎的异种移植物模型中，TDP-43 功能丧失和边缘空泡在 T 细胞耗竭后仍然存在。

Sci Transl Med. 2022 Jan 19;14(628):eabi9196. doi: 10.1126/scitranslmed.abi9196.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验